DFNA9 Clinical Trial - Genotype-phenotype Correlation Study of

Status Recruiting

Clinical Trial Summary

DFNA9 (Deafness Autosomal Dominant 9) is an autosomal dominant hereditary hearing loss which is associated with vestibular deterioration. The most recent genotype-phenotype correlation studies have been conducted more than 15 years ago. Meanwhile, emerging and valuable vestibular tests have been added to the vestibular test battery. These tests were not available at the time of the correlation studies. The aim of this study is to carry out a prospective cross-sectional study on symptomatic and presymptomatic affected carriers of the Pro51Ser (P51S) Coagulation Factor C Homology (COCH) mutation in order to correlate vestibular data using the complete vestibular test battery with the known data on hearing and vestibular function in relation to age.

Clinical Trial Description

Systematic review of the genotype-phenotype correlation studies in P51S carriers has shown an underrepresentation of presymptomatic affected subjects and the calculation of vestibular deterioration were based on just one vestibular parameter, whereas the combined evaluation of a complete vestibular test battery, covering the complete vestibular sensitivity range and all labyrinthine compartments separately, is nowadays considered standard practice in determining more accurate assessment of the vestibular function. For this reason, a prospective cross-sectional study on pre- as well as symptomatic DFNA9 patients carrying the Pro51Ser (P51S) mutation in COCH gene is being carried out, in order to gain more realistic data on vestibular dysfunction, consisting of pure tone audiometry and a comprehensive vestibular test battery, including electro- or videonystagmography (VNG), C- and O-Vestibular-evoked myogenic potential (VEMP) tests, video Head Impulse Test (vHIT) and questionnaires (DHI (Dizziness handicap Index), oscillopsia questionnaire (OS), Quality of Life Questionnaire (EQ-5D-5L), activities-specific balance confidence (ABC) scale. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03716908
Study type	Observational [Patient Registry]
Source	Jessa Hospital
Contact	sebastien PF JanssensdeVarebeke, MD
Phone	011337420
Email	sebastien.janssensdevarebeke@jessazh.be
Status	Recruiting
Phase
Start date	June 1, 2018
Completion date	November 30, 2026

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02533739` - Vestibular Disorder and Visuo-spatial Functions	N/A
Completed	`NCT00271791` - Prednisone Treatment for Vestibular Neuronitis	Phase 2
Recruiting	`NCT06332326` - Investigation of the Efficacy of Non-Invasive Vagus Nerve Stimulation and Physiotherapy in Unilateral Vestibular Hypofunction Patients	N/A
Completed	`NCT01483937` - Evaluation of a Sensory Enrichment Multimodal Device (SEMD) on Physical Therapy Patients With Disequilibrium	N/A
Recruiting	`NCT05634902` - Implementation of Evidence-Based Practice for Dizziness	N/A
Recruiting	`NCT05436067` - Individualized Vestibular Rehabilitation for Elderly With Self-Management and Gaming Elements	N/A
Completed	`NCT02753179` - Covert-saccades, Dynamic Visual Acuity and Quality of Life	N/A
Completed	`NCT03160352` - Effects of Exergames on Vestibular Function in Healthy Community Dwellers.	N/A
Completed	`NCT03887923` - Vestibular Physical Therapy for People With Alzheimer Disease	N/A
Terminated	`NCT01305278` - The Efficacy of Balance Gaming as an Adjunct to Vestibular Rehabilitation Therapy	N/A
Completed	`NCT03464214` - The Effects of Local Vibration and Cervical Stabilization Exercises Applied on Neck Muscles on Balance in Healthy Individuals	N/A
Recruiting	`NCT03799991` - Vestibular Therapy in Alzheimer's Disease	N/A
Completed	`NCT02722486` - Use of a Vibrotactile Balance Belt System for Vestibular Rehabilitation in the Pediatric Population	N/A
Not yet recruiting	`NCT06350669` - App-supported Vestibular Rehabilitation (RCT)	N/A
Completed	`NCT00768378` - Safety and Efficacy Study of BrainPort® Balance Device in Peripheral Vestibular Dysfunction.	N/A
Withdrawn	`NCT03578354` - 4-Aminopyridine, Atenolol, or Placebo in Patients With Vestibular Migraine	Phase 2
Completed	`NCT00702832` - Effect of Vestibular Rehabilitation - a Randomized Controlled Trial	N/A
Recruiting	`NCT00146952` - Use of a Vibrotactile Sensory Prosthesis in Patients With Postural Imbalance and Spatial Disorientation	Phase 1
Recruiting	`NCT05674786` - Vestibular Implantation to Treat Adult-Onset Bilateral Vestibular Hypofunction	N/A
Completed	`NCT02417545` - Gaze and Stair Walking in Patients With Vestibular Dysfunction	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Genotype-phenotype Correlation Study of Presymptomatic and Symptomatic DFNA9 Patients

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms